Histopathological classification of hepatocellular carcinoma

被引:48
作者
Roncalli, Massimo [1 ,2 ]
Park, Young Nyun [3 ]
Di Tommaso, Luca [1 ,2 ]
机构
[1] Univ Milan, Sch Med, Dept Pathol, Milan, Italy
[2] IRCCS Ist Clin Humanitas, Milan, Italy
[3] Yonsei Univ, Coll Med, Brain Korea Project Med Sci 21, Dept Pathol,Ctr Chron Metab Dis, Seoul 120752, South Korea
关键词
Dysplasia; Early/progressed HCC; Hepatocarcinogenesis; Stem/progenitor cell;
D O I
10.1016/S1590-8658(10)60510-5
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Recent advances in the understanding of HCC heterogeneity have shown not only distinct molecular classes with potential therapeutical implications but also have suggested that subclasses might be mirrored by tumour morphology and phenotype. The classification of HCC is therefore shifting from a more traditional, morphology-based approach to a more functional approach with clinical implications. The classical histological patterns (trabecular, pseudoglandular, solid, etc.) are still taken into account but in combination with other parameters such as cell grading, clonal changes, type and extent of vascularisation, tumour immunophenotype etc. This array of morpho-phenotypical features is expected to ultimately provide information about cell of origin, tumour behaviour and, hopefully, treatment sensitivity. In this chapter we will give a brief overview on modern principles of hepatic carcinogenesis by outlining the events/lesions bridging the microscopic dysplasia to advanced HCC. In this context special emphasis will be given to novel concepts and diagnostics and differential diagnosis of small HCC (of early and progressed type), which is the main target of the surveillance in the cirrhotic population. Novel and emerging subpopulations of HCC will also be considered, for example HCC with stem/progenitor cell phenotype and mixed hepatobiliary forms which are filling the traditional separation between two entities (HCC and cholangiocarcinoma), likely more inter-related than previously thought. (C) 2010 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:S228 / S234
页数:7
相关论文
共 33 条
  • [1] Characterization of small nodules in cirrhosis by assessment of vascularity: The problem of hypovascular hepatocellular carcinoma
    Bolondi, L
    Gaiani, S
    Celli, N
    Goffieri, R
    Grigioni, WF
    Leoni, S
    Venturi, AM
    Piscaglia, F
    [J]. HEPATOLOGY, 2005, 42 (01) : 27 - 34
  • [2] Impact of large regenerative, low grade and high grade dysplastic nodules in hepatocellular carcinoma development
    Borzio, M
    Fargion, S
    Borzio, F
    Fracanzani, AL
    Croce, AM
    Stroffolini, T
    Oldani, S
    Cotichini, R
    Roncalli, M
    [J]. JOURNAL OF HEPATOLOGY, 2003, 39 (02) : 208 - 214
  • [3] Transcriptome classification of HCC is related to gene alterations and to new therapeutic targets
    Boyault, Sandrine
    Rickman, David S.
    de Reynies, Aurelien
    Balabaud, Charles
    Rebouissou, Sandra
    Jeannot, Emmanuelle
    Herault, Aurelie
    Saric, Jean
    Belghiti, Jacques
    Franco, Dominique
    Bioulac-Sage, Paulette
    Laurent-Puig, Pierre
    Zucman-Rossi, Jessica
    [J]. HEPATOLOGY, 2007, 45 (01) : 42 - 52
  • [4] Induction of a unique gene expression profile in primary human hepatocytes by hepatitis C virus core, NS3 and NS5A proteins
    Budhu, A.
    Chen, Y.
    Kim, J. W.
    Forgues, M.
    Valerie, K.
    Harris, C. C.
    Wang, X. W.
    [J]. CARCINOGENESIS, 2007, 28 (07) : 1552 - 1560
  • [5] Diagnostic value of HSP70, glypican 3, and glutamine synthetase in hepatocellular nodules in cirrhosis
    Di Tommaso, Luca
    Franchi, Giada
    Park, Young Nyun
    Fiamengo, Barbara
    Destro, Annarita
    Morenghi, Emanuela
    Montorsi, Marco
    Torzilli, Guido
    Tommasini, Maurizio
    Terracciano, Luigi
    Tornillo, Luigi
    Vecchione, Raffaella
    Roncalli, Massimo
    [J]. HEPATOLOGY, 2007, 45 (03) : 725 - 734
  • [6] The application of markers (HSP70 GPC3 and GS) in liver biopsies is useful for detection of hepatocellular carcinoma
    Di Tommaso, Luca
    Destro, Annarita
    Seok, Jae Yeon
    Balladore, Emanuela
    Terracciano, Luigi
    Sanglovanni, Angelo
    Iavarone, Massimo
    Colombo, Massimo
    Jang, Ja June
    Yu, Eunsil
    Jin, So Young
    Morenghi, Emanuela
    Park, Young Nyun
    Roncalli, Massimo
    [J]. JOURNAL OF HEPATOLOGY, 2009, 50 (04) : 746 - 754
  • [7] From proteomic analysis to clinical significance - Overexpression of cytokeratin 19 correlates with hepatocellular carcinoma metastasis
    Ding, SJ
    Li, Y
    Tan, YX
    Jiang, MR
    Tian, B
    Liu, YK
    Shao, XX
    Ye, SL
    Wu, JR
    Zeng, R
    Wang, HY
    Tang, ZY
    Xia, QC
    [J]. MOLECULAR & CELLULAR PROTEOMICS, 2004, 3 (01) : 73 - 81
  • [8] The clinicopathological and prognostic relevance of cytokeratin 7 and 19 expression in hepatocellular carcinoma. A possible progenitor cell origin
    Durnez, A.
    Verslype, C.
    Nevens, F.
    Fevery, J.
    Aerts, R.
    Pirenne, J.
    Lesaffre, E.
    Libbrecht, L.
    Desmet, V.
    Roskams, T.
    [J]. HISTOPATHOLOGY, 2006, 49 (02) : 138 - 151
  • [9] Hepatocellular carcinoma pathogenesis: from genes to environment
    Farazi, Paraskevi A.
    DePinho, Ronald A.
    [J]. NATURE REVIEWS CANCER, 2006, 6 (09) : 674 - 687
  • [10] Diagnosis of hepatic nodules 20 mm or smaller in cirrhosis:: Prospective validation of the noninvasive diagnostic criteria for hepatocellular carcinoma
    Forner, Alejandro
    Vilana, Ramon
    Ayuso, Carmen
    Bianchi, Lluis
    Sole, Manel
    Ayuso, Juan Ramon
    Boix, Loreto
    Sala, Margarita
    Varela, Maria
    Llovet, Josep M.
    Bru, Concepcio
    Bruix, Jordi
    [J]. HEPATOLOGY, 2008, 47 (01) : 97 - 104